Get started
Author

Rogério Serafim Parra

Observed names: Parra RS, Parra Rogerio, Parra, Rogério Serafim, R S Parra, R Serafim Parra, R. Parra, R. S. Parra, R.S. Parra, R.s. Parra, ROGÉRIO SERAFIM PARRA, Rogerio S. Parra, Rogerio Parra, Rogerio S Parra, Rogerio S. Parra, Rogerio Serafim PARRA, Rogerio Serafim Parra, Rogério Parra, Rogério S Parra, Rogério S. Parra, Rogério Serafim PARRA, RogérioSerafim Parra
Observed institutions: Universidade Federal da Bahia, Universidade de Brasília, Universidade de São Paulo, Instituto Nacional de Cancerología, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Clinics Hospital of Ribeirão Preto, Hospital São Paulo, Universidade Federal do Paraná, University of Chile, Universidade Estadual Paulista (Unesp)
ORCID: 0000-0002-5566-9284
Observed ORCID: 0000-0002-5566-9284
OpenAlex ID: A5082054325
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
2022 · Bruce E Sands, Peter M Irving, et al. · The Lancet · 308
PDF
Risankizumab for Ulcerative Colitis
2024 · Edouard Louis, Stefan Schreiber, et al. · JAMA · 134
PDF
Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil
2019 · Rogerio S Parra, Julio MF Chebli, et al. · World Journal of Gastroenterology · 90
PDF
Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress
2022 · Pedro V. da Silva-Neto, Valéria B. do Valle, et al. · Biomolecules · 57
PDF
sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity
2021 · Pedro V. da Silva-Neto, Jonatan C. S. de Carvalho, et al. · Viruses · 48
PDF
Spontaneous transvaginal small bowel evisceration: a case report
2010 · Rogério Serafim Parra, José Joaquim Ribeiro da Rocha, et al. · Clinics · 46
PDF
Hyperbaric oxygen therapy decreases mortality due to Fournier’s gangrene
2021 · Omar Féres, Marley Ribeiro Feitosa, et al. · Medical Gas Research · 38
Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity
2022 · Malena M Pérez, Vinícius E Pimentel, et al. · The Journal of Immunology · 35
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician
2021 · Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, et al. · World Journal of Gastroenterology · 35
Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats
2015 · Rogério S Parra, Alexandre H Lopes, et al. · Medical Gas Research · 33
PDF
Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy
2024 · Jean-Frédéric Colombel, Tadakazu Hisamatsu, et al. · Clinical Gastroenterology and Hepatology · 32
The impact of laparoscopic surgery on the symptoms and wellbeing of patients with deep infiltrating endometriosis and bowel involvement
2020 · Rogério Serafim Parra, Marley Ribeiro Feitosa, et al. · Journal of Psychosomatic Obstetrics & Gynecology · 31
Familial adenomatous polyposis and desmoid tumors
2011 · Ana Elisa Moraes Righetti, Cristiane Jacomini, et al. · Clinics · 29
PDF
Adjunctive Hyperbaric Oxygen Therapy promotes successful healing in patients with refractory Crohn's disease
2016 · Marley Ribeiro Feitosa, Omar Féres Filho, et al. · Acta Cirúrgica Brasileira · 27
PDF
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study
2022 · Rogério Serafim Parra, Júlio Maria Fonseca Chebli, et al. · BMC Gastroenterology · 25
PDF
Effect of hyperbaric oxygen therapy on the intestinal ischemia reperfusion injury
2011 · Rosemary Aparecida Furlan Daniel, Vinícius Kannen Cardoso, et al. · Acta Cirúrgica Brasileira · 25
PDF
Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
2021 · Cyrla Zaltman, Rogério Serafim Parra, et al. · World Journal of Gastroenterology · 22
Inflammatory Bowel Disease Care in Brazil: How It Is Performed, Obstacles and Demands From the Physicians’ Perspective
2020 · Eduardo Garcia VILELA, Henrique Carvalho ROCHA, et al. · Arquivos de Gastroenterologia · 22
PDF
Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn’s Disease: An Observational Study
2021 · Marley R. Feitosa, Rogério S. Parra, et al. · Gastroenterology Research and Practice · 21
PDF
Crohn's disease and hyperbaric oxygen therapy
2011 · Leonardo Estenio Iezzi, Marley Ribeiro Feitosa, et al. · Acta Cirúrgica Brasileira · 21
PDF
Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
2018 · Rogério S. Parra, Marley R. Feitosa, et al. · Gastroenterology Research and Practice · 18
PDF
Anemia and Iron Deficiency in Inflammatory Bowel Disease Patients in a Referral Center in Brazil: Prevalence and Risk Factors
2020 · Rogério Serafim PARRA, Marley Ribeiro FEITOSA, et al. · Arquivos de Gastroenterologia · 17
PDF
PPARG expression in colorectal cancer and its association with staging and clinical evolution
2020 · Andre Luiz Prezotto Villa, Rogério Serafim Parra, et al. · Acta Cirúrgica Brasileira · 17
PDF
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease
2024 · Subrata Ghosh, Brian G Feagan, et al. · Journal of Crohn s and Colitis · 16
Second Brazilian Consensus on the Management of Crohn’s Disease in Adults: a Consensus of the Brazilian Organization for Crohn’s Disease and Colitis (gediib)
2023 · Marcello IMBRIZI, Júlio Pinheiro BAIMA, et al. · Arquivos de Gastroenterologia · 16
PDF
Works count: 339
Citation count: 1,544
H-index: 20
I10-index: 37
Year
Topic
Type